Respiratory symptoms increase health care consumption and affect everyday life – a cross-sectional population-based study from Finland, Estonia, and Sweden-Reference-Cited by-同舟云学术

Respiratory symptoms increase health care consumption and affect everyday life – a cross-sectional population-based study from Finland, Estonia, and Sweden

Published:2016-01 Issue:1 Volume:3 Page:31024
ISSN:2001-8525
Container-title:European Clinical Respiratory Journal
language:en
Short-container-title:European Clinical Respiratory Journal

Author:

Axelsson Malin¹,Lindberg Anne²,Kainu Annette³,Rönmark Eva⁴,Jansson Sven-Arne⁴

Affiliation:

1. Department of Care Science, Faculty of Health and Society, Malmö University, Malmö, Sweden

2. Department of Public Health and Clinical Medicine, Division of Medicine, The OLIN Unit, Umeå University, Umeå, Sweden

3. HUCH Heart and Lung Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland

4. Department of Public Health and Clinical Medicine, Occupational and Environmental Medicine, The OLIN Unit, Umeå University, Umeå, Sweden

Publisher

Informa UK Limited

Subject

Pulmonary and Respiratory Medicine

Link

https://www.tandfonline.com/doi/pdf/10.3402/ecrj.v3.31024

Reference8 articles.

1. Epidemiology of respiratory symptoms, lung function and important determinants

2. Predictors of dyspnoea prevalence: results from the BOLD study

3. Smoking, Respiratory Symptoms, and Diseases

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is there still a social gradient in respiratory symptoms? A population-based Nordic EpiLung-study;Respiratory Medicine;2024-03

2. Introduction of a systematic examination framework for chronic cough: a before-after cohort study in a clinical setting;European Clinical Respiratory Journal;2023-01

3. All-Cause and Cause-Specific Mortality in Respiratory Symptom Clusters: A Population-Based Multicohort Study;2023

4. Respiratory symptoms and their determinants in the general Spanish population: changes over 20 years;ERJ Open Research;2022-10

5. NSAID-exacerbated respiratory disease: a population study;ERJ Open Research;2022-01